SecBot SecBot
F-1 ·Filed Jul 24, 2026

MBAI

Check-Cap Ltd
MIXED
Impact 7/10
Horizonweeks Processed3mo ago SEC0001213900-26-081494
Foreign IPO registration
Actionable Insight ◆ Mixed

The IPO is a critical funding event for Check-Cap's survival and the MBody AI merger. Monitor the final offering size and price, and the Nasdaq listing decision for the combined entity. The merger's success is highly dependent on MBody AI's ability to scale customer deployments and achieve positive cash flow.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
MBAI ▼ -68.36% at T+60d
NEUTRAL call -68.36% · α vs SPY -72.41% · entry $1.07 → $0.3386
Entry = T+0 close
Jul 24, 2026
via day close
T+1d
-1.87%
call -1.87% · α -2.11%
$1.05
settled 3mo ago
T+5d
+5.61%
call +5.61% · α +3.09%
$1.13
settled 3mo ago
T+20d
+7.34%
call +7.34% · α +4.04%
$1.15
settled 2mo ago
T+60d
-68.36%
call -68.36% · α -72.41%
$0.3386
settled 8d ago

Executive Summary

Check-Cap Ltd. files a firm-commitment IPO F-1 registration statement to sell ordinary shares, with proceeds intended to fund the pending merger with MBody AI Corp, acquire robotic systems, develop the MBody AI Orchestrator platform, and for working capital. The merger is expected to close in H2 2026, with former MBody AI equityholders owning ~90% of the combined company. The filing is a critical capital raise for a company with a going-concern warning and a history of losses, but the proceeds are earmarked for a transformative business combination with a pre-revenue AI robotics firm.

Key Facts

  • Check-Cap is a clinical-stage medical diagnostics company with a going-concern warning and $219K in cash as of Dec 31, 2025.
  • The company has entered into a merger agreement with MBody AI Corp, an embodied AI company, expected to close in H2 2026.
  • Upon merger close, former MBody AI equityholders will own ~90% of the combined company, and Check-Cap shareholders ~10%.
  • This F-1 is a firm-commitment IPO underwriting by Northland Securities; proceeds are to fund the merger, acquire robotic systems, and develop the MBody AI Orchestrator platform.
  • MBody AI has a limited operating history, is substantially dependent on two customers (MGM and Caesars), and has negative operating cash flow despite achieving profitability in 2025.
  • Check-Cap has a history of losses and substantial doubt about its ability to continue as a going concern.
  • The offering size and price are not yet determined (placeholders in the filing).
  • The merger is contingent on Nasdaq initial listing approval; the offering is contingent on such listing.
  • Check-Cap has a $30M purchase agreement with ARC Group for an at-the-money equity line, under which it has already sold 683K shares for ~$1.0M.

Financial Impact

Undisclosed amount; proceeds from the IPO will be used to fund the MBody AI merger, acquire robotic systems, and for working capital. Check-Cap had $219K cash as of Dec 31, 2025.

cashdilutionrevenuegoing concern

Risk Factors

  • Going-concern risk if the IPO or merger fails to close.
  • Massive dilution to existing Check-Cap shareholders (expected to own ~10% post-merger).
  • MBody AI's extreme customer concentration (MGM and Caesars) and negative operating cash flow.
  • Nasdaq delisting risk if the combined company fails to meet initial listing standards.
  • The merger is subject to conditions and may not close on the anticipated timeline or at all.

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
F-1 Filing (Primary)0001213900-26-081494
Document: ea029719601ex1-1.htm0001213900-26-081494
Document: ea029719601ex99-1.htm0001213900-26-081494
16 reports for MBAI
Performance horizon
100% Hit rate @ T+5 6 of 6 directional calls Went positive at some point 6 of 6 best @ T+20▲ +59.78%Sep 22, 2026
Filters
Rows
Reports for MBAI — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
Press Release
NEUTRAL ★ 4/10
$2.05awaiting T+5—$2.07 (+0.73%)
Sep 29, 2026
27d ago
EFFECT
NEUTRAL ★ 4/10
$3.75 $3.24▼ −13.60%▼ −15.55%$2.07 (−44.93%)
Sep 22, 2026
4w ago
SC 13D
NEUTRAL ★ 4/10
$5.47 $3.54▼ −35.28%▼ −34.61%$2.07 (−62.25%)
Sep 22, 2026
4w ago
6-K
BEARISH ★ 6/10
$5.47 $3.54▲ +35.28%▲ +34.61%$2.07 (+62.25%)
Sep 16, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$6.33 $5.47▼ −13.59%▼ −15.41%$2.07 (−67.38%)
Sep 16, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$6.33 $5.47▼ −13.59%▼ −15.41%$2.07 (−67.38%)
Aug 28, 2026
8w ago
Press Release
MIXED ★ 7/10
$6.61 $6.37▼ −3.71%▼ −3.56%$2.07 (−68.76%)
Aug 28, 2026
8w ago
6-K
BEARISH ★ 7/10
$6.58 $6.50▲ +1.22%▲ +1.32%$2.07 (+68.62%)
Aug 27, 2026
8w ago
424B4
MIXED ★ 7/10
$6.57 $6.50▼ −1.07%▼ −1.33%$2.07 (−68.57%)
Aug 26, 2026
8w ago
6-K
BEARISH ★ 7/10
$6.78 $6.48▲ +4.42%▲ +4.30%$2.07 (+69.54%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (13h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 24, 2026